You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Everolimus

Showing 1 - 25 of 1,264
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Aging, Insulin Resistance Trial in Madison (Everolimus 0.5 MG once per day, Everolimus 5 MG once per week, Placebo once per day)

Recruiting
  • Aging
  • Insulin Resistance
  • Everolimus 0.5 MG once per day
  • +3 more
  • Madison, Wisconsin
    University of Wisconsin-Madison
Apr 19, 2023

Breast Cancer, Advanced Breast Cancer Trial in Shanghai (Everolimus 10 mg, CDK4/6 Inhibitor SHR6390, Aromatase inhibitor and

Not yet recruiting
  • Breast Cancer
  • Advanced Breast Cancer
  • Everolimus 10 mg
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 14, 2023

Meningioma Trial in Vandœuvre-lès-Nancy (Everolimus)

Not yet recruiting
  • Meningioma
  • Everolimus
  • Vandœuvre-lès-Nancy, Grand Est, France
  • +1 more
Nov 8, 2023

Gallbladder Cancer Trial in Varanasi (Everolimus 10 mg, Standard of care)

Recruiting
  • Gallbladder Cancer
  • Everolimus 10 mg
  • Standard of care
  • Varanasi, UP, India
    Banaras Hindu University
Apr 18, 2023

HR+/HER2- Advanced Breast Cancer, Targeted Therapy Trial in Beijing (Everolimus, Chidamide, Endocrine therapy)

Recruiting
  • HR+/HER2- Advanced Breast Cancer
  • Targeted Therapy
  • Everolimus
  • +3 more
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Aug 1, 2023

Classical Hodgkin Lymphoma Trial in Philadelphia (Itacitinib, Everolimus)

Active, not recruiting
  • Classical Hodgkin Lymphoma
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Nov 28, 2022

Uterine Sarcoma Trial (Everolimus)

Available
  • Uterine Sarcoma
  • Everolimus
  • (no location specified)
Aug 25, 2022

Epilepsy Trial in Shenyang (Everolimus, Placebo)

Recruiting
  • Epilepsy
  • Everolimus
  • Placebo
  • Shenyang, Liaoning, China
    Shengjing Hospital of China Medical University
Nov 5, 2022

Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of

Not yet recruiting
  • Triple Negative Breast Cancer
  • +2 more
  • Everolimus
  • Investigator's Choice of Chemotherapy
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 25, 2023

Advanced Cancers, Solid Tumors Trial in Houston (Pazopanib, Everolimus)

Active, not recruiting
  • Advanced Cancers
  • Solid Tumors
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 16, 2022

Idiopathic Subglottic Tracheal Stenosis Trial in Baltimore (Everolimus Oral Tablet)

Recruiting
  • Idiopathic Subglottic Tracheal Stenosis
  • Everolimus Oral Tablet
  • Baltimore, Maryland
    Johns Hopkins Outpatient Center
Jul 28, 2022

Thymoma and Thymic Carcinoma Trial in Rozzano (Everolimus)

Completed
  • Thymoma and Thymic Carcinoma
  • Everolimus
  • Rozzano, MI, Italy
    Istituto Clinico Humanitas
Sep 8, 2022

Kidney Transplant Infection, BK Virus Infection Trial in Bangkok (Everolimus, reduced dose tacrolimus)

Recruiting
  • Kidney Transplant Infection
  • BK Virus Infection
  • Everolimus
  • reduced dose tacrolimus
  • Bangkok, Thailand
    King Chulalongkorn Memorial Hospital
Nov 10, 2022

Glioblastoma Multiforme, Glioma of Brain Trial in Chandler, Phoenix, Scottsdale (Ribociclib, Everolimus)

Completed
  • Glioblastoma Multiforme
  • Glioma of Brain
  • Chandler, Arizona
  • +2 more
Jan 11, 2023

Renal Angiomyolipoma Trial (Everolimus)

Not yet recruiting
  • Renal Angiomyolipoma
  • Everolimus
  • (no location specified)
Aug 15, 2022

Breast Cancer Trial in Birmingham (Letrozole, Everolimus, TRC105)

Active, not recruiting
  • Breast Cancer
  • Birmingham, Alabama
    University of Alabama at Birmingham
Dec 13, 2022

Glioma, High Grade Glioma, Pontine Tumors Trial in Ann Arbor (Dasatinib, Everolimus)

Terminated
Has Results
  • Glioma
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Cancer Center
Sep 26, 2022

Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Everolimus, Laboratory

Recruiting
  • Advanced Malignant Neoplasm
  • +3 more
  • Everolimus
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 9, 2022

Restenosis Trial in Ostrava (paclitaxel-coated balloon catheter with Iopromide coating, drug eluting stent with everolimus,

Completed
  • Restenosis
  • paclitaxel-coated balloon catheter with Iopromide coating
  • +2 more
  • Ostrava, Czechia
    University Hospital
Dec 6, 2022

Gastrointestinal Stromal Tumor Trial (Everolimus)

Temporarily not available
  • Gastrointestinal Stromal Tumor
  • Everolimus
  • (no location specified)
May 5, 2022

Percutaneous Coronary Intervention (PCI), Coronary Artery Disease (CAD), De Novo Stenosis Trial in Tunis (DEB for de Novo

Recruiting
  • Percutaneous Coronary Intervention (PCI)
  • +2 more
  • DEB for de Novo Lesions
  • DES for de Novo Lesions
  • Tunis, Tunisia
    Military hospital of Tunis
Aug 23, 2022

Advanced Carcinoid Tumor, Digestive System Neuroendocrine Tumor, Multiple Endocrine Neoplasia Type 1 Trial in Houston

Recruiting
  • Advanced Carcinoid Tumor
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Aging Trial in Madison (Sirolimus, Everolimus)

Not yet recruiting
  • Aging
  • Madison, Wisconsin
    University of Wisconsin
Jul 17, 2023

Endometrial Cancer Trial in Morristown, Houston (Letrozole, RAD001 (Everolimus))

Active, not recruiting
Has Results
  • Endometrial Cancer
  • Morristown, New Jersey
  • +1 more
Nov 16, 2022

Stomatitis, Oral Mucositis, Tumor of the Breast Trial in US (Miracle Mouthwash Plus Hydrocortisone, Prednisolone)

Completed
  • Stomatitis
  • +3 more
  • US, Texas
    12 sites incl Yakima, WA, Boulder, CO, and Austin, TX
Nov 29, 2022